- 期刊
Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
延伸閱讀
- Sauter, M., Kastenmüller, K., Belling, F., Wörnle, M., Ladurner, R., Mussack, T., & Sitter, T. (2012). Activation of Peroxisome Proliferator-Activated Receptor-Gamma by Glitazones Reduces the Expression and Release of Monocyte Chemoattractant Protein-1 in Human Mesothelial Cells. Mediators of Inflammation, 2012(), 314-319. https://doi.org/10.1155/2012/217696
- Kuo, H. L. (2016). Study on the role of Peroxisome Proliferator-Activated Receptors (PPARs) in the immune regulatory activities during mesenchymal stem cell differentiation [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201602124
- Foti, D. P., Paonessa, F., Chiefari, E., & Brunetti, A. (2009). New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor. PPAR Research, 2009(), 202-209. https://doi.org/10.1155/2009/571365
- Matsuyama, M., & Yoshimura, R. (2008). Peroxisome Proliferator-Activated Receptor-γ Is a Potent Target for Prevention and Treatment in Human Prostate and Testicular Cancer. PPAR Research, 2008(), 296-307-026. https://doi.org/10.1155/2008/249849
- Grau, R., Muñoz, M. D. D., Llaguno, C. C., Fresno, M., & Iñiguez, M. A. (2008). Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth. PPAR Research, 2008(), 507-516-046. https://doi.org/10.1155/2008/352437